Blue Crest Capital Management LTD Bluebird Bio, Inc. Transaction History

Blue Crest Capital Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $956,190 - $1.33 Million	-12,608 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $812,459 - $1.31 Million	12,608 New	12,608 $1.98 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $1.5 Million - $2.37 Million	-25,416 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $1.32 Million - $1.75 Million	-14,906 Reduced 36.97%	25,416 $3.71 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $2.73 Million - $3.49 Million	27,368 Added 211.27%	40,322 $6.33 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $1.37 Million - $1.96 Million	12,954 New	12,954 $2.21 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.